| scholarly article | Q13442814 |
| P2093 | author name string | Lewis L Lanier | |
| Rayna Takaki | |||
| Jonathan Benjamin | |||
| Kouetsu Ogasawara | |||
| Joseph H Phillips | |||
| P2860 | cites work | Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D | Q28214530 |
| Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain | Q28300502 | ||
| Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice | Q28591835 | ||
| NK cell recognition | Q29615107 | ||
| Tolerance and alloreactivity of the Ly49D subset of murine NK cells. | Q30752033 | ||
| Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants | Q30836316 | ||
| Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets | Q32067027 | ||
| Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f | Q33267529 | ||
| Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo | Q34078028 | ||
| Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. | Q34153562 | ||
| NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer | Q34197825 | ||
| Roles of the NKG2D immunoreceptor and its ligands | Q34267094 | ||
| The molecular and functional characterization of a dominant minor H antigen, H60. | Q34473903 | ||
| Structure and function of natural killer cell surface receptors | Q35019697 | ||
| Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice | Q36271368 | ||
| Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection | Q36353538 | ||
| Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts | Q36356601 | ||
| Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized | Q36357551 | ||
| Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity | Q36367724 | ||
| NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules | Q36370410 | ||
| The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions | Q36399282 | ||
| Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. | Q40460772 | ||
| Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts | Q40828092 | ||
| Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules | Q41230767 | ||
| Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts | Q42936891 | ||
| Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L. | Q44201393 | ||
| Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. | Q46027985 | ||
| DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming | Q46091534 | ||
| NKG2D blockade prevents autoimmune diabetes in NOD mice | Q46294168 | ||
| Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells | Q46757843 | ||
| Impairment of NK cell function by NKG2D modulation in NOD mice | Q46830266 | ||
| Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. | Q54288133 | ||
| Induction of Immunity and of Unresponsiveness to Parental Marrow Grafts in Adult F1 Hybrid Mice | Q58956448 | ||
| Requirement for IRF-1 in the microenvironment supporting development of natural killer cells | Q59098134 | ||
| Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. | Q64990108 | ||
| Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes | Q69925991 | ||
| The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts | Q70934066 | ||
| Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells | Q71017483 | ||
| Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum | Q72552114 | ||
| Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells | Q78109788 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| P304 | page(s) | 938-945 | |
| P577 | publication date | 2005-08-07 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts | |
| P478 | volume | 6 |
| Q33319278 | A role for NKG2D in NK cell-mediated resistance to poxvirus disease |
| Q34195904 | Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis |
| Q36652183 | Activation and self-tolerance of natural killer cells |
| Q36652207 | Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self |
| Q33709427 | Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells |
| Q42666043 | Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice |
| Q41660377 | Anti-NKG2D mAb: A New Treatment for Crohn's Disease? |
| Q37218092 | Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation |
| Q37696132 | Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice |
| Q37559284 | Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells |
| Q36733439 | Blockade of individual Notch ligands and receptors controls graft-versus-host disease |
| Q36058551 | CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice |
| Q58620998 | Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1ε with NK Cells Impacts NKG2D Expression and Function |
| Q95327696 | Clonal expansion of innate and adaptive lymphocytes |
| Q36851896 | Continuous engagement of a self-specific activation receptor induces NK cell tolerance |
| Q51838387 | Cytotoxicity of Natural Killer Cells Activated Through NKG2D Contributes to the Development of Bronchiolitis Obliterans in a Murine Heterotopic Tracheal Transplant Model. |
| Q37361459 | DAP10- and DAP12-associated receptors in innate immunity |
| Q39227235 | DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells |
| Q37764003 | Effect of NKG2D ligand expression on host immune responses |
| Q79448782 | Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance |
| Q36915675 | Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand |
| Q34489980 | Genetics, genomics, and evolutionary biology of NKG2D ligands |
| Q37157198 | HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. |
| Q33522918 | Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells |
| Q36787596 | Human natural killer cells |
| Q28570224 | Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection |
| Q86946448 | In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity |
| Q35816814 | Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms |
| Q34550147 | Innate immune recognition and suppression of tumors |
| Q37864689 | Innate immunity in transplant tolerance and rejection |
| Q33914699 | Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1 |
| Q37400135 | LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation |
| Q36342130 | MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination |
| Q53906830 | Mechanisms of tolerance. |
| Q36200587 | Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade |
| Q55234629 | More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells. |
| Q37922581 | NK cell development, homeostasis and function: parallels with CD8⁺ T cells |
| Q92615060 | NK cell recognition of hematopoietic cells by SLAM-SAP families |
| Q36813516 | NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand |
| Q38187574 | NK cells after transplantation: friend or foe. |
| Q53460599 | NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. |
| Q35687826 | NKG2D Receptor and Its Ligands in Host Defense |
| Q42590545 | NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses |
| Q54234609 | NKG2D and Its Ligands: "One for All, All for One". |
| Q38229037 | NKG2D and its ligands: active factors in the outcome of solid organ transplantation? |
| Q36354709 | NKG2D in NK and T cell-mediated immunity |
| Q37287179 | NKG2D ligands in tumor immunity |
| Q36484099 | NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis |
| Q36484325 | NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy |
| Q34508406 | NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells |
| Q55216305 | NKG2D: A Master Regulator of Immune Cell Responsiveness. |
| Q35095243 | NKG2D⁺ IFN-γ⁺ CD8⁺ T cells are responsible for palladium allergy |
| Q58785734 | Natural Killer Cells: Development, Maturation, and Clinical Utilization |
| Q37721591 | Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation. |
| Q37672011 | Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation |
| Q37789866 | Natural killer cell education and tolerance |
| Q34087767 | Natural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo |
| Q37397516 | Natural killer cell tolerance licensing and other mechanisms. |
| Q37524719 | Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses |
| Q36652177 | Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity |
| Q36900826 | Promiscuity and the single receptor: NKG2D. |
| Q34161487 | Re-educating natural killer cells |
| Q34496462 | Recognition of tumors by the innate immune system and natural killer cells |
| Q34360228 | Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. |
| Q37256962 | Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells |
| Q24635093 | Regulation of immune cell function and differentiation by the NKG2D receptor |
| Q36872056 | Regulation of ligands for the activating receptor NKG2D. |
| Q92845900 | Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway |
| Q36518933 | Self-tolerance of natural killer cells |
| Q34600272 | Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells |
| Q35792738 | Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT |
| Q36757142 | T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice |
| Q38178966 | The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells. |
| Q36278732 | The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation |
| Q41684097 | The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. |
| Q37056344 | The NKG2D receptor: immunobiology and clinical implications. |
| Q55001650 | The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease. |
| Q35757045 | The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits |
| Q82452966 | The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT |
| Q33265158 | The nonopsonic allogeneic cell phagocytosis of macrophages detected by flow cytometry and two photon fluorescence microscope |
| Q34450450 | The requirement for NKG2D in NK cell–mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient |
| Q36851891 | Tolerance of NK cells encountering their viral ligand during development |
| Q36447590 | Transplant tolerance in non-human primates: progress, current challenges and unmet needs |
| Q37900760 | Unifying concepts of MHC-dependent natural killer cell education |
| Q55019451 | Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells. |
Search more.